What people report
MOTS-c reviews: what people report
Read 32 people, 3 sitesPublished by PepVault
Of the 32 people whose MOTS-c write-ups we read, 20 describe a change they wanted (17 more energy or strength; 2 clearer thinking, memory or mood), 5 noticed nothing and 7 describe something unwanted.
What people report
20 of the 32 people describe at least one change they wanted. Each bar counts the people who named anything in that group, once each, out of all 32; the line under it says what they named, and how many named it. 8 of them took MOTS-c alongside other peptides at the same time.
What went wrong or did nothing
7 of the 32 people describe something they didn’t want, and 5 noticed nothing at all.
Your report
Taken MOTS-c? What did you notice?
One tap to start. About 30 seconds, no account.

When people say it begins
4 of the 32 people say when they first noticed something; 28 don’t.
What people took it for
1 of the 32 people say what they took it for; 31 don’t.
How it’s thought to work
Shown in animals or cells
MOTS-c is a short peptide made from the mitochondria’s own genes and found in human blood; its level rises with exercise and falls with age. In mice it raised running capacity and insulin sensitivity by switching on AMPK, the cell’s fuel sensor. It has not been given to people in a published trial.
Sources: Lee et al., 2015: insulin resistance and weight in mice; Reynolds et al., 2021: physical decline in old mice
What studies show
Our research section has 12 study pages on MOTS-c: 7 in mice, 3 in rats, 1 in people and 1 in lab-grown cells.
No published trial has given MOTS-c to people; the one study in people on our list measured the body’s own MOTS-c, which rose in breast cancer survivors after 16 weeks of exercise.
- MOTS-c rose after 16 weeks of exercise in non-Hispanic White survivors
- MOTS-c reduced islet cell senescence and glucose intolerance in mice
- MOTS-c eased lung ischemia-reperfusion injury and deaths in rats
- MOTS-c improved heart mitochondrial respiration in diabetic rats
- MOTS-c prevented muscle atrophy, raised muscle glucose uptake in mice
- MOTS-c raised testosterone, LH and FSH in obese and non-obese rats
- MOTS-c improved heart small-vessel barrier under endotoxin in mice
- MOTS-c: a single dose raised running distance 15% in untrained mice
- MOTS-c eased high blood sugar in mice with gestational diabetes
- MOTS-c improved physical performance in young, middle-age and old mice
- MOTS-c prevented diet-induced obesity and insulin resistance in mice
- MOTS-c lowered insulin, raised glucagon in pancreatic cell lines
- MOTS-c in the library: how it works, half-life and evidence
- Is MOTS-c legal? FDA, DEA and WADA status
- MOTS-c dose guide
Where the reports run ahead of the studies
17 of the 32 people describe more energy or stamina, often with SS-31 and NAD+ in the same weeks. No trial in people has tested it; in mice it raised running capacity (PubMed, searched November 19, 2026).
Where the reports come from
32 people on 23 pages across 3 sites, written from January 2024 to November 2026. Read on November 19, 2026.
The largest single site, X, gave 16 of the 32.
Peptide Critic, which runs its forum, also runs a shop on its own site that sells injection pens and supplies, not peptides.
Many people here took MOTS-c with SS-31 and NAD+ as one “mitochondria stack”, so some of these reports are about the set. The itchy welt where it goes in is the commonest thing the forum posters write about.
- Peptide Critic forum, a thread on a strange MOTS-c reaction: 6 people
- Peptide Critic forum, a thread for people taking SS-31 for the first time: 3 people
- rapamycin.news forum, the peptides and bioregulators thread: 3 people
- Peptide Critic forum, a thread on MOTS-c and blood pressure: 1 person
- Peptide Critic forum, a thread on peptides that surprised people: 1 person
- Peptide Critic forum, the SS-31 protocol thread: 1 person
- rapamycin.news forum, the SS-31 thread: 1 person
- X, public posts: 16 people (post · post · post · post · post · post · post · post · post · post · post · post · post · post · post · post)
Read and not counted
- A Peptide Critic forum staff member’s posts: The same account posts the forum’s vendor sales roundups, and the site runs its own store: the seller’s side of the counter, so not counted.
- A rapamycin.news member who supplies peptides to clients: Posts at length about the dosing he and his family and clients use: the seller’s side of the counter, so not counted.
- Posts that started MOTS-c with no outcome yet: Plans and first days; nothing noticed was said.
- Reports about someone else (a wife, a friend’s wife, a partner): Second-hand; only a person’s own report counts.
- Posts about vendors, testing, prices and dosing with no effect named: Most posts in these threads; nothing noticed was said.
- Posts on X from coaches or vendors, or with no outcome: A coach asking for messages, a vendor, a retelling of someone else, stacks where the effect was put on another compound, explainers and news, and questions or plans with nothing noticed; not counted.
- Reddit: Not part of this count.
How we counted
We read every open write-up we could find by people who took MOTS-c, on its own page, and counted each person once however often they posted, including those who noticed nothing. Sellers, clinics, shop reviews and anyone who earns on a sale are not counted, and neither is a search result’s snippet; the list above names what we read and left out. Write-ups lean positive, because people who notice nothing rarely write about it and expecting an effect can produce one. People on X and on the forums can’t be matched to each other, so someone who wrote in both places may be counted twice.
Spot an error? feedback@pepvault.app. How we research. This page reports what people say; it is not medical advice.